While the activation of ERK1/2 in tumor cells mainly induces immune-resistance and immune-escape, the physiological activation of ERK in immune populations leads to their proliferation, resulting in pro-tumor or anti-tumor effects depending on the type of population expanded. Here, MAPK3 is linked to neoplasm.